FDA Drug Application (074701) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by MYLAN

Back to FDA Applications sponsored by MYLAN

Application Number074701
Product Number001
FormCAPSULE;ORAL
Dosage25MG;37.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TRIAMTERENE5


Back to FDA Applications sponsored by MYLAN